文献速递泌尿生殖USMR

经直肠超声引导下认知融合靶向活检诊断移行区前列腺癌:基于活检前MRI与超声表现

Transrectal ultrasound-guided targeted biopsy of transition zone prostate cancer under cognitive registration with prebiopsy MRI and sonographic findings.
PubMed 文献 · Clin Radiol · 2019-10-31

回顾性评估38例活检前MRI患者的经直肠超声引导下移行区靶向活检,采用单一有经验放射科医师的认知融合。任何前列腺癌检出率78.9%(30/38),临床显著前列腺癌42.1%(16/38);中断中线征见于50%(19/38)患者,对移行区前列腺癌预测值达94.7%(18/19)。

要点

  • 移行区前列腺癌超声回声表现多样,仅50%呈低回声,26.7%为中回声、23.3%为高回声。
  • 中断中线征在MRI和超声上均可见,出现于50%患者,对移行区前列腺癌预测值94.7%。
  • 认知融合靶向活检对移行区任何前列腺癌检出率78.9%,临床显著前列腺癌42.1%。

关键影像表现/征象

  • 移行区前列腺癌超声回声表现多样:低回声50%、中等回声26.7%、高回声23.3%。
  • 中断中线征定义为在MRI和超声上均可见的跨越移行区中线的局灶性病灶导致中线不连续,见于50%(19/38)患者。
  • 中断中线征对移行区前列腺癌预测值为94.7%(18/19)。

诊断标准与关键数值

  • 临床显著前列腺癌定义为Gleason评分≥7的移行区前列腺癌。
  • 靶向活检对移行区任何前列腺癌检出率为78.9%(30/38)。
  • 靶向活检对移行区临床显著前列腺癌检出率为42.1%(16/38)。
  • 靶向病灶MRI采用前列腺影像报告和数据系统第2版(PI-RADSv2)评分评估。

临床应用与阅片要点

  • 认知融合靶向活检时可参考中断中线征,该征象对移行区前列腺癌有高预测值(94.7%)。
  • 移行区前列腺癌超声回声多样,仅半数呈低回声,靶向时不应仅依赖低回声。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate retrospectively the diagnostic usefulness of transrectal ultrasound (TRUS)-guided targeted biopsy (TB) for transition zone (TZ) prostate cancer (PCa) in patients with prebiopsy magnetic resonance imaging (MRI).

MATERIALS AND METHODS: A consecutive series of 38 patients who underwent TRUS-guided TB of TZ lesions were evaluated. TB (mean core number, 2.4±0.6; range, 2-4) was performed by a single experienced radiologist under cognitive registration between prebiopsy MRI and TRUS. Tumour echogenicity on TRUS and Prostate Imaging-Reporting and Data System version 2 (PI-RADSv2) scoring on MRI for targeted TZ lesions were assessed. The interrupted midline sign was defined as a focal lesion traversing the midline of the TZ leading to discontinuity of the midline on both MRI and TRUS. TZ PCa with a Gleason score of 7 or greater was defined as clinically significant PCa (csPCa).

RESULTS: The cancer detection rate of TRUS-guided TB for TZ lesions was 78.9% (30/38) for any PCa and 42.1% (16/38) for csPCa. Echogenicity of TZ PCa on TRUS was various and half did not show low echogenicity (low, 50%; intermediate, 26.7%; and high, 23.3%). The interrupted midline sign was identified in 50% (19/38) of patients, which was highly predictive of TZ PCa (94.7%, 18/19).

CONCLUSION: TRUS-guided TB under cognitive registration based on prebiopsy MRI findings is useful to detect TZ PCa. Knowledge of the sonographic features of TZ PCa may help to target TZ PCa accurately under cognitive registration.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Won SY, Cho NH, Choi YD, et al. Transrectal ultrasound-guided targeted biopsy of transition zone prostate cancer under cognitive registration with prebiopsy MRI and sonographic findings. Clin Radiol. 2019. PMID: 31677880. doi:10.1016/j.crad.2019.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。